Making an Impact
The liver is a central metabolic organ that coordinates the healthy functioning of the heart, brain and kidneys.
Liver diseases are the hardest to see and treat. We’re tackling them with new ways to prevent, stop or reverse them. We are reinventing the way we care for our patients and how we educate future physician-scientists.
And that helps more people avoid suffering and live longer, healthier lives.
Spotlight
NEWS
VCU hepatologist R. Todd Stravitz donates $25M to AASLD to bolster growth in early-career liver disease research
Mon, Nov 18, '24
NEWSLETTER
November 2024 newsletter
Wed, Nov 13, '24
NEWS
More than 40% of U.S. adults have liver disease, with higher risk among Hispanics, VCU-led study finds
Tue, Nov 12, '24
BLOG
VCU-led Study Finds No Difference Among Corticosteroids in Treating Severe Alcohol-Related Hepatitis
Tue, Nov 12, '24
Learn about the vision of VCU’s Stravitz-Sanyal Institute for Liver Disease and Metabolic Health from its founders. The institute is investing in research to stop, prevent and reverse liver disease: a leading factor for the decline in life expectancy in the U.S.
